Pulmatrix, Inc. SEC filings PULM
Pulmatrix, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 24, 2013. Its latest annual report, Form ARS, was filed on Oct 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 7, 2026 | — |
| DEFM14A | Filing | Sep 25, 2026 | — |
| DEF 14A | Proxy statement | Nov 8, 2024 | Nov 8, 2024 |
| DEF 14A | Proxy statement | Jun 2, 2023 | Jun 2, 2023 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| DEFA14A | Additional proxy material | Feb 1, 2022 | — |
| DEFA14A | Additional proxy material | Dec 30, 2021 | — |
| DEF 14A | Proxy statement | Dec 30, 2021 | Dec 30, 2021 |
| PRE 14A | Preliminary proxy statement | Dec 20, 2021 | Dec 20, 2021 |
| DEFA14A | Additional proxy material | Dec 17, 2021 | — |
| DEFA14A | Additional proxy material | Dec 17, 2021 | — |
| DEFA14A | Additional proxy material | Dec 15, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Apr 29, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEFA14A | Additional proxy material | May 27, 2020 | — |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 17, 2020 |
| DEFA14A | Additional proxy material | Jul 26, 2019 | — |
| DEF 14A | Proxy statement | Jul 26, 2019 | Sep 6, 2019 |
| DEFA14A | Additional proxy material | Apr 26, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 5, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2018 | Apr 13, 2018 |
| DEFA14A | Additional proxy material | Apr 28, 2017 | — |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 8, 2017 |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEF 14A | Proxy statement | Apr 14, 2016 | May 24, 2016 |
| DEF 14A | Proxy statement | Mar 3, 2015 | Mar 26, 2015 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PULM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Framingham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1574235
- Former names
- Ruthigen, Inc. (until Jun 16, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.